Alpha DNA Investment Management’s FIVE9 FIVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-10,844
Closed -$441K 75
2024
Q4
$441K Buy
+10,844
New +$391K 0.17% 141
2023
Q3
Sell
-9,815
Closed -$809K 187
2023
Q2
$809K Buy
+9,815
New +$659K 0.27% 91
2021
Q3
Sell
-8,085
Closed -$1.48M 123
2021
Q2
$1.48M Buy
8,085
+3,824
+90% +$659K 1.01% 44
2021
Q1
$666K Sell
4,261
-209
-5% -$35.7K 0.77% 47
2020
Q4
$779K Buy
+4,470
New +$680K 0.83% 45

Other funds holding FIVN

Alpha DNA Investment Management's FIVN Position: Q1 2025 in Review

Alpha DNA Investment Management sold out of FIVE9 (FIVN) in Q1 2025, closing a stake of 10,844 shares — an estimated $441K sold.

Alpha DNA Investment Management first reported a position in FIVN in Q4 2020 and held it in 5 quarters. The position peaked at $1.48M in Q2 2021. 306 funds tracked by Wall St. Rank hold FIVN as of Q1 2025.

  • Alpha DNA Investment Management reported no remaining FIVE9 position as of Q1 2025 after selling out during the quarter.
  • Alpha DNA Investment Management sold 10,844 FIVE9 shares in Q1 2025, an estimated $441K.
  • Alpha DNA Investment Management first reported a position in FIVE9 in Q4 2020 and held it in 5 quarters.
  • Alpha DNA Investment Management's FIVE9 position peaked at $1.48M in Q2 2021.
  • 306 funds tracked by Wall St. Rank held FIVE9 as of Q1 2025.

Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.